Search
for
Sort by
Research 541–570 of 823
- Oestrogen functions in skin and skin appendages
- Dermatology of androgen-related disorders
- Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis
- Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families
- Sex Steroid Hormone Receptors in Human Skin Appendage and its Neoplasms
- Regulatory roles of androgens in cutaneous wound healing
- Clinical, ultrasound and hormonal markers of androgenicity in acne vulgaris
- Menopause and aging, quality of life and sexuality
- Differences in Perceptions of Beauty and Cosmetic Procedures Performed in Ethnic Patients
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- The spectrum of hair loss in patients with mycosis fungoides and Sézary syndrome
- Pregnancy and the Skin
- Physiological Skin Changes During Pregnancy
- Differential Diagnosis of Hyperandrogenism in Women with Polycystic Ovary Syndrome
- Androgens in women
- Retrospective evaluation of sex hormones and steroid hormone intermediates in dogs with alopecia
- PLASMA C19 STEROID SULPHATE LEVELS AND INDICES OF ANDROGEN BIOAVAILABILITY IN FEMALE PATTERN ANDROGENIC ALOPECIA
- Female pattern hair loss, sebum excretion and the end-organ response to androgens
- Oral Contraceptives and Cyproterone Acetate in Female Acne Treatment
- Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male)
- Alterations in Hair Follicle Dynamics in Women
- Congenital adrenal hyperplasia
- Hair Loss in Systemic Disease
- INTERFERONS IN DERMATOLOGY
- Is polycystic ovary syndrome a sexual conflict? A review
- Topical Minoxidil Therapy and Hair Regrowth
- Dissecting folliculitis (dissecting cellulitis) of the scalp: a 66‐patient case series and proposal of classification
- Do Different Diagnostic Criteria Impact Polycystic Ovary Syndrome Diagnosis for Adolescents?
- Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk